Yatharth Hospital & Trauma Care Services Ltd Downgraded to Sell Amid Technical and Valuation Concerns
NiveshIQ
Yatharth Hospital & Trauma Care Services Ltd.
NiveshIQ has detected 5 active signals on YATHARTH. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeAbout Yatharth Hospital & Trauma Care Services Ltd.
Yatharth Hospital & Trauma Care Services Limited is a leading healthcare provider in India, operating super-specialty hospitals across the country. The company offers a wide range of medical services, including cardiology, neurosciences, general surgery, and more, with a focus on providing high-quality patient care. With a strong presence in the Indian healthcare market, Yatharth Hospital has established itself as a trusted brand, attracting a large patient base. The company's diversified service offerings, including medicine sales and canteen food, contribute significantly to its revenue. In FY26, the promoters confirmed no share encumbrance, indicating a strong financial position. Yatharth Hospital's growth outlook is promising, driven by increasing demand for quality healthcare services
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹635.00 Cr +32.80% | ₹860.00 Cr +35.40% | ₹1,207 Cr +40.40% |
| EBITDA Margin | 28.66% | 26.16% | 26.33% |
| Net Profit | ₹114.00 Cr +72.70% | ₹131.00 Cr +14.90% | ₹170.30 Cr +30.00% |
| EPS | ₹13.33 | ₹13.55 | ₹18.20 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Yatharth Hospital and Trauma Care Services Limited Revenue Breakdown – NSE:YATHARTH
Yatharth Hospital Highlights Advanced Neurological Care and Inspiring Recovery Stories on World Brain Day
Strategic Outlook
- Q4FY26 results: revenue ₹342 Cr, PAT ₹45 Cr, EPS ₹4.93, EBITDA margin 25.5%. Growth context: revenue QoQ +6.7%, PAT QoQ +4.0%. Street verdict: miss, revenue surprise +0.9%, PAT surprise -9.0%.
Management commentary highlights order wins, deal pipeline, and backlog build as key near-term growth drivers, with exec...
FY26 (last completed FY): revenue ₹1, 207 Cr, PAT ₹170 Cr, EBITDA margin 26.3%, EPS ₹18.20. Year-on-year: revenue YoY +4...
Everything you unlock with a free account
Frequently Asked Questions
What AI signals does NiveshIQ provide for Yatharth Hospital & Trauma Care Services Ltd.?
NiveshIQ detects active intelligence signals for Yatharth Hospital & Trauma Care Services Ltd. (YATHARTH) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Yatharth Hospital & Trauma Care Services Ltd.?
Yatharth Hospital & Trauma Care Services Ltd. operates in the Healthcare sector with a market capitalisation of ₹830,574.6L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.